Total assets increased 17.8%
Total assets changed +17.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +17.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -596 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -322 basis points from the comparable as-filed period.
Shares outstanding changed +18.9% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating income changed -55.8% from the comparable as-filed period.
Free-cash-flow proxy changed -61.6% from the comparable as-filed period.
Inventory changed +14.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -42.7% from the comparable as-filed period.
Research & development changed +69.4% from the comparable as-filed period.
Reported total debt changed +41.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross debt changed +41.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory / revenue changed +655 basis points from the comparable as-filed period.
Capex / revenue changed +887 basis points from the comparable as-filed period.
Shares outstanding changed +22.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Current liabilities changed +18.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +15.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -56.9% from the comparable as-filed period.
Operating margin changed -269 basis points from the comparable as-filed period.
Operating cash flow changed +84.9% from the comparable as-filed period.
Research & development changed +49.2% from the comparable as-filed period.
Revenue changed +25.5% from the comparable as-filed period.
Net debt changed +29.2% from the comparable as-filed period.
Reported total debt changed +54.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross debt changed +54.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +141.8% from the comparable as-filed period.
Capex / revenue changed +986 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.